An open-label, multiple dose, fixed-sequence, 3-period study to evaluate the drug interaction between CKD-519 and rosuvastatin in healthy male subjects.
The purpose of this study is to evaluate the drug interaction between CKD-519 and rosuvastatin in healthy male subjects.